《沙门氏菌和天然抗菌药物敏感性的菌株生物膜形成的环境》

  • 来源专题:食物与营养
  • 编译者: lixiaoman
  • 发布时间:2016-07-08
  • 本研究的目的是通过精油减少生物膜中的沙门氏菌。从传统的养猪场环境中可以得出生物膜是由15株沙门氏菌的形成的,是由96孔板结晶紫和最低生物膜清除浓度(MBEC)检测评价的。所有沙门氏菌菌株形成生物膜都在MBEC中试验,但是,这些菌株的疏水性没有显着差异。天然的抗菌剂,以减少沙门氏菌在生物膜的杀菌效果,这些抗菌剂的杀菌作用随浓度增加。

相关报告
  • 《德克萨斯乳品农场环境下样品沙门氏菌的患病率与抗菌药物的敏感性》

    • 来源专题:食物与营养
    • 编译者:潘淑春
    • 发布时间:2016-03-24
    • Dairy cattle are a reservoir of several Salmonella serovars that are leading causes of human salmonellosis. The objectives of this study were to estimate the environmental prevalence of Salmonella on dairy farms in Texas and to characterize the antimicrobial susceptibility of the isolates. Eleven dairy farms throughout Texas were sampled from August through October 2013, using a cross-sectional approach. Samples were collected from four locations within each farm (hospital pen, maternity pen, cow housing area, and calf housing area), and feces were collected from cull cows as available. Environmental and fecal samples were processed for Salmonella, and isolates were tested for susceptibility to 15 antimicrobial agents. Serovar characterization was performed on a subset of these isolates. Salmonella was isolated from 67.0% (236/352) of the environmental samples and 64.2% (43/67) of the cull cow fecal samples. Environmental samples from the maternity pen were significantly more likely to be Salmonella positive than samples from the cow and calf housing areas. Multidrug resistance was evident in 11.9% (27/226) of environmental isolates and 19.5% (8/41) of fecal isolates. Salmonella isolates from the calf housing area and maternity pen were significantly more likely to be multidrug resistant (MDR) than isolates from the cow housing area. The most common serovars found among the MDR isolates were Newport, Muenchen, and Typhimurium. These results help provide a focus for efforts to mitigate the burden of antimicrobial-resistant Salmonella at the preharvest level.
  • 《2016年欧洲淋球菌抗菌药物的敏感性监测》

    • 来源专题:动植物疫病
    • 编译者:刘小燕
    • 发布时间:2018-10-21
    • 欧洲淋球菌抗菌药物敏感性监测(Euro-GASP)的总体目标是加强对欧盟/欧洲经济区成员国淋球菌抗菌药物敏感性的监测,以便提供有质量保证的数据,为淋病治疗指南提供信息。本次报告介绍了2016年淋菌性抗菌药物敏感性哨点监测的结果。2016年,欧洲淋球菌抗菌药物监测计划(Euro-GASP)遵循年度分散和集中测试模式,要求参与实验室在9月至11月期间收集淋球菌分离株。并对所有分离株进行药敏试验。对于以下抗微生物剂:头孢克肟、头孢曲松、环丙沙星、庆大霉素、壮观霉素和阿奇霉素以及监测β-内酰胺酶的产量从而监测出高水平的青霉素抗性。分散测试在参与实验室的场所进行,需要符合设定的质量标准。2016年,有25个欧盟/欧洲经济区成员国参与了Euro-GASP计划,17个通过了分散测试。共收集并测试了2660株分离株,覆盖了常规监测所捕获的4%的淋病病例。其中大多数是从男性患者收集到的淋球菌分离物(85.1%)。2016年抗菌药物敏感性数据显示,头孢克肟和阿奇霉素耐药性稳定(2.1%和7.5%),环丙沙星的抗性是46.5%。其中头孢曲松耐药性的缺乏可能部分归因于目前高效的双重治疗方案(头孢克松和阿奇霉素)。新型抗菌药和新的双重抗菌治疗方案以及持续监测对于确保淋病仍然可以治疗至关重要。